Neuropsychiatric manifestations in SLE. Susanne Benseler MD @RheumNow #ACR24 https://t.co/subiykC5Q4

• https://x.com/synovialjoints/status/1858591546930794555/photo/1

A#2586 EBIO study - secukinumab on entheseal bx in PsA. Compare b/l to 3+ mo on SEC Biopsy: change of entheseal cell composition on IL-17A Rx - decr Il-17A producing cells in responding pts Spatial transcriptomics - colocalizarjon of ILC2, CD200+ fibroblasts @RheumNow #ACR24 https://t.co/kMiqpBRxuE

• https://x.com/ericdeinmd/status/1858593064912028040/photo/1

Neuroimaging is done to support the diagnosis of CNS #lupus but only 75% reveal abnormal brain MRI. 📌 It is more useful in pts with local deficits than diffuse. 📌 poorly correlated with cognitive dysfunction & psych phenotypes. @Rheumnow #ACR24 @rheumarhyme @theactiverheum https://t.co/HjNbVBaOHv

• https://x.com/RHEUMarampa/status/1858594297068568866/photo/1

The different NPSLE syndromes 👇 Highlighted in yellow are the most common manifestations. 🧠 - Cognitive dysfunction - Mood disorder - Anxiety disorder @RheumNow #ACR24 https://t.co/1I7OVPT6DK

• https://x.com/RHEUMarampa/status/1858594961786368109/photo/1

A higher number of axSpA pts enrolled in BE MOBILE 1&2 who were treated with BKZ achieved remission accdg to the OSI vs. ASDAS ID (40.5% vs 15.2%) at wk 16 until wk 52. OSI a better measure of remission? @RheumNow #ACR24 abs2362 https://t.co/GCHjXQi9S9

• https://x.com/RHEUMarampa/status/1858595035559932201/photo/1

Diagnostic work up for neuropsychiatric SLE. Zahi Touma MD @RheumNow #ACR24 https://t.co/zLX1QHCaSu

• https://x.com/synovialjoints/status/1858596785477894242/photo/1

Dr @ZahiTouma discusses the attribution rules for the NPSLE syndromes Attribute to #SLE if - onset of NP is near the SLE dx - absence of concurrent nonSLE factors - ⬇️ frequency of NP events in the gen pop'n - diagnostic tools favor NPSLE @RheumNow #ACR24 https://t.co/e1xBK4Xzsw

• https://x.com/RHEUMarampa/status/1858601757196382237/photo/1

Very informative slide describing the 2 NPSLE pathogenetic pathways & their differences in mediators, mechanisms and NP events. @RheumNow #ACR24 @rheumarhyme @theactiverheum https://t.co/D3XFDqxMBq

• https://x.com/RHEUMarampa/status/1858601773818114364/photo/1

Walsh et al. Direct mailing of PEST questionnaire to psoriasis patients. 13% PEST+, 4% seen by rheum (to date). 75% deemed appropriate for rheum to see - breakdown in picture. @RheumNow #ACR24 Abstr#2635 https://t.co/vlGJ977SV7 https://t.co/dbDUpwDZxy

• Direct to Patient Screening for Psoriatic Arthritis in Patients with Psoriasis:…
• https://x.com/RichardPAConway/status/1858602829146960258/photo/1

Sharma @Amansharmapgi et al. DADA2. Clinical manifestations of 101(!) patients. @RheumNow #ACR24 Abstr#2647 https://t.co/Tkk6Rz6rtT https://t.co/frvFPYy4xf

• Clinical Characteristics , Treatment Outcomes and Predictors of Mortality in a …
• https://x.com/RichardPAConway/status/1858603584356774002/photo/1

A#2647 DADA2 cohort 101 pts in India Median delay dx 5 years - 5 pts of >20 yr - 39 pts w GI involvement- bad outcomes Skin most common - largely livedo, then ulcers/nodules CNS common w ischemia Many Rx before dx 12 deaths (11.8%) - 8 GI, 3 CVA, 1 suicide #ACR24 @RheumNow https://t.co/Q8kiVbJq8I

• https://x.com/ericdeinmd/status/1858603919494050241/photo/1
• https://x.com/ericdeinmd/status/1858603919494050241/photo/1

A call to action in diagnosing and treating NPSLE 👇 Wonderful talks by Dr @ZahiTouma Dr. Betty Diamond and Dr. Susanne Benseler @Rheumnow #ACR24 #lupus https://t.co/046ArRMP1a

• https://x.com/RHEUMarampa/status/1858605373986623942/photo/1

Medeiros-Ribeiro et al. Holding MTX for 2 weeks after recombinant zoster vaccine increases response with no increase in flare. @RheumNow #ACR24 Abstr#2612 https://t.co/NEop0XB5Ak https://t.co/P4S2qzbkTs

• Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients…
• https://x.com/RichardPAConway/status/1858606100754407799/photo/1

SmPCs recommend interrupting immunosuppression (IS) in infection What happens if you continue the drug? Ab2611 found no difference in infection outcomes btwn temp interruption & continuation of IS in infection Could continuation be a safe option in some pts? #ACR24 @RheumNow https://t.co/14SN6a4Wm8

• https://x.com/DrMiniDey/status/1858606604293468406/photo/1

RIP to Glucocorticoids in GPA For many years glucocorticoids were the mainstay of our treatment of granulomatosis with polyangiitis (GPA). https://t.co/WqpO6ACqtu https://t.co/vb8qx3uHA0

• RIP to Glucocorticoids in GPA | RheumNow